Product Brochure

Understanding The 505(b)(2) Approval Pathway

Format: PDF file | Document type: Product Brochure | Promoted Content

This content is provided by Camargo Pharmaceutical Services, and any views and opinions expressed do not necessarily reflect those of

Understanding The 505(b)(2) Approval Pathway

By the time he founded Camargo Pharmaceutical Services in 2003, Ken Phelps had already amassed more than 30 years of experience in the health science and services industry. With a broad background in drug development, specifically the 505(b)(2) regulatory approval pathway, Phelps has aided in the successful FDA approval of numerous compounds. Today, his company provides a full spectrum of drug development capabilities, from pre-clinical feasibility assessments to clinical program development to regulatory review and submission.

Related resources from Camargo Pharmaceutical Services

Show more

Supplier info centre